This is the program for the 2010 Joint Statistical Meetings in Vancouver, British Columbia.
Abstract Details
Activity Number:
|
221
|
Type:
|
Topic Contributed
|
Date/Time:
|
Monday, August 2, 2010 : 2:00 PM to 3:50 PM
|
Sponsor:
|
Biopharmaceutical Section
|
Abstract - #307283 |
Title:
|
Evaluation of Design Parameters for an Adaptive Seamless Phase 2b/3 Trial
|
Author(s):
|
Susan Y. Zhou*+ and Greg Soon and Xiao Ding and JungYeon Park and EunYoung Kim and Sue-Jane Wang
|
Companies:
|
CDER/FDA and CDER/FDA and CDER/FDA and CDER/FDA and CDER/FDA and FDA
|
Address:
|
10903 New Hampshire Ave., Silver Spring, MD, 20993,
|
Keywords:
|
adaptive seamless phase 2b/3 trial ;
HIV-1 drug ;
short-term efficacy endpoint ;
long-term efficacy endpoint ;
meta-analysis ;
Missing
|
Abstract:
|
Currently, an adaptive seamless Phase 2b/3 trial (ASPT) comparing the efficacy and safety of two doses of a new HIV-1 drug to a comparator HIV-1 drug was pursued. The design parameters include a short-term (ST) efficacy endpoint (EE) for dose confirmation and a long-term efficacy endpoint (LTEE) for regulatory purposes (Stallard and Todd, 2005), and an additional LTEE to formulate data structures. To ensure the quality of study design, simulation studies were performed to evaluate the type I/II errors. We derived formulae for the correlation coefficient of the originally defined EEs, and verified the adequacy of the proposed design parameters. Employing historical data, we conducted meta-analyses to model the designed parameters and predicted the treatment differences for selected scenarios. Research findings and the variability in the design parameters of the ASPT will be discussed.
|
The address information is for the authors that have a + after their name.
Authors who are presenting talks have a * after their name.
Back to the full JSM 2010 program
|
2010 JSM Online Program Home
For information, contact jsm@amstat.org or phone (888) 231-3473.
If you have questions about the Continuing Education program, please contact the Education Department.